These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4258201)

  • 1. The identification of fibrinogen derivatives in plasma and serum by agarose gel filtration.
    Vermylen J; Donati MB; Verstraete M
    Scand J Haematol Suppl; 1971; 13():219-23. PubMed ID: 4258201
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen derivatives in a case of abruptio placentae.
    Graeff H; von Hugo R
    Am J Obstet Gynecol; 1974 Oct; 120(3):335-40. PubMed ID: 4213114
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrophoretic pattern and reactivity of fibrinogen degradation products (FDP) in three assays.
    Niewiarowski S; Nandi M; Colman RW; Bloch KJ
    Scand J Haematol Suppl; 1971; 13():129-35. PubMed ID: 4258198
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical significance of fibrinogen-fibrin-related antigen in serum.
    Merskey C; Johnson AJ
    Scand J Haematol Suppl; 1971; 13():313-5. PubMed ID: 4258204
    [No Abstract]   [Full Text] [Related]  

  • 5. The Tanned Red Cell Hemagglutination Inhibition Immunoassay and purified fibrinogen degradation products.
    Donati MB; Molla A; Vermylen J
    Scand J Haematol Suppl; 1971; 13():91-9. PubMed ID: 4258208
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinogen breakdown products: identification and assay in serum and urine.
    Rayner H; Parashevas F; Israels LG; Israels ED
    J Lab Clin Med; 1969 Oct; 74(4):586-96. PubMed ID: 4241717
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alterations in coagulation and fibrinolytic system in abruptio placentae (author's transl)].
    Saito H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Apr; 34(4):529-37. PubMed ID: 7069257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A COAGULATION ANOMALY: PLASMA BEING MADE NON-CLOTTABLE BY ADDING THROMBIN, AND CLOTTABLE BY THROMBOPLASTIN-CALCIUM OR TOLUIDINE BLUE-THROMBIN.V5 BLUE-THROMBIN.
    MAKI M; KIKUCHI K; WATANABE S; KIKUCHI E
    Tohoku J Exp Med; 1964 Dec; 84():274-81. PubMed ID: 14244484
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of thromboplastin in a case of abruptio placentae with hypofibrinogenemia.
    Skjodt P
    Acta Obstet Gynecol Scand; 1967; 46(1):19-40. PubMed ID: 6025354
    [No Abstract]   [Full Text] [Related]  

  • 10. The results of a comparison of the tanned red cell hemagglutination inhibition immuno-assay with an immunochemical method for the determination of splitproducts.
    Bouma BN
    Scand J Haematol Suppl; 1971; 13():111-4. PubMed ID: 4258197
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypofibrinogenemic states in obstetrics.
    Sise HS
    J Reprod Med; 1973 Mar; 10(3):115-7. PubMed ID: 4266545
    [No Abstract]   [Full Text] [Related]  

  • 12. Defibrination in obstetrics. Modern concepts.
    Kleiner GJ; Greston WM
    S Afr Med J; 1975 Mar; 49(12):446-52. PubMed ID: 807977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defibrination in normal and abnormal parturition.
    Kleiner GJ; Merskey C; Johnson AJ; Markus WB
    Br J Haematol; 1970 Aug; 19(2):159-78. PubMed ID: 5453919
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of fibrinogen degradation products by a sandwich enzyme immunoassay technique.
    Tanaka M; Minesaki M; Kato K
    Clin Chim Acta; 1980 May; 103(3):287-95. PubMed ID: 6772346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrination syndrome in an infant born after abruptio placentae.
    Edson JR; Blaese RM; White JG; Krivit W
    J Pediatr; 1968 Mar; 72(3):342-6. PubMed ID: 5639747
    [No Abstract]   [Full Text] [Related]  

  • 16. HAEMORRHAGIC DIATHESIS DUE TO ABRUPTIO PLACENTAE TREATED BY FIBRINOGEN, EPSILON-AMINOCAPROIC ACID, AND HYSTEROTOMY.
    BONNAR J; CRAWFORD JM
    Lancet; 1965 Jan; 1(7379):241-3. PubMed ID: 14238067
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and haematological problems associated with severe abruptio placentae.
    Odendaal HJ; Brink S; Steytler JG
    S Afr Med J; 1978 Sep; 54(12):476-80. PubMed ID: 734577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [INHIBITORS OF FIBRINOLYSIS IN THE NEWBORN].
    GABURRO D; PANIZZA GF; BONIFACI E
    Ann Pediatr (Paris); 1964 Jan; 11():53-7. PubMed ID: 14129367
    [No Abstract]   [Full Text] [Related]  

  • 19. A rapid test for abruptio placentae: evaluation of a D-dimer latex agglutination slide test.
    Nolan TE; Smith RP; Devoe LD
    Am J Obstet Gynecol; 1993 Aug; 169(2 Pt 1):265-8; discussion 268-9. PubMed ID: 8362935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen derivatives. A laboratory and clinical study.
    Vermylen J
    Verh K Vlaam Acad Geneeskd Belg; 1972; 34(2):125-208. PubMed ID: 4278099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.